ARCHIVES

NCI Reportedly Gets $691 Million From House, Senate Conferees

This article is from The Cancer Letter archive.

Vol. 01 No. 35 | October 4, 1974

Download PDF Visit The Full Archive

Related Articles

FDA Ponders Standards For “Retrospective Prospective” Studies

January 30, 2009

Groups Warn Against Cuts In Research, Seek Funds For NCI

February 10, 1995

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

April 15, 1977

NEJM Does About-Face, Issues Correction On CT Lung Cancer Screening Study.

April 4, 2008

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

September 3, 1993

M.D. Anderson Breast Cancer Studies Promising NEJM Publishes Bonadnna Report

February 27, 1976